Moreover, blocking PPARα signaling using a specific inhibitor, GW6471, was sufficient to reduce LD accumulation and abrogate the effects of PIM1 induction prostate cancer proliferation (Fig. 4). The gene discussed is PPARA; the disease is prostate carcinoma.